Status:
UNKNOWN
Assessment of Histologic Prognostic Factors in Peritoneal Malignant Mesothelioma
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Peritoneal Malignant Mesothelioma
Eligibility:
All Genders
18-80 years
Brief Summary
Malignant peritoneal mesothelioma is a rare neoplasm. The most common type, the epithelioid type, has been further divided into histological patterns of tubulo-papillary, acinar, adenomatoid, micropap...
Eligibility Criteria
Inclusion
- \- peritoneal malignant mesothelioma
Exclusion
- opposition to reuse personnal data
Key Trial Info
Start Date :
December 28 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05193006
Start Date
December 28 2021
End Date
January 1 2023
Last Update
January 14 2022
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Gent
Ghent, Belgium, 9000
2
University Hospital of Lyon
Pierre-Bénite, France, 69495
3
Institut f. Pathologie und Neuropathologie
Tübingen, Germany, 72076
4
Zydus Hospitals
Ahmedabad, India